Bath & Body Works (NYSE:BBWI) Shares Down 3.3% – Time to Sell?

Shares of Bath & Body Works, Inc. (NYSE:BBWI) fell 3.3% during mid-day trading on Tuesday . The stock traded as low as $18.52 and last traded at $18.5390. 1,114,994 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 5,640,770 shares. The stock had previously closed at $19.17.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Piper Sandler initiated coverage on Bath & Body Works in a research note on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. Telsey Advisory Group decreased their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a report on Thursday, May 28th. Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price for the company in a research report on Tuesday, August 18th. Barclays cut their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. Finally, Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $22.57.

Bath & Body Works Trading Down 3.9%

The firm has a market capitalization of $3.71 billion, a P/E ratio of 5.17, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38. The firm has a 50 day moving average price of $20.46 and a 200-day moving average price of $20.06.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts anticipate that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Hedge Funds Weigh In On Bath & Body Works

A number of large investors have recently made changes to their positions in the company. Global Retirement Partners LLC bought a new position in Bath & Body Works during the 4th quarter valued at about $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $32,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the last quarter. Finally, Danske Bank A S bought a new position in shares of Bath & Body Works during the third quarter valued at approximately $39,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.